• 대한생식의학회:학술대회논문집
• /
• 대한불임학회 2006년도 The 5th Biannual Meeting of Pacific Rim Society for Fertility and Sterility
• /
• pp.12-17
• /
• 2006

• Journal of Cardiovascular Imaging
• /
• 제31권2호
• /
• pp.105-107
• /
• 2023

• The Journal of Korean Physical Therapy
• /
• 제22권4호
• /
• pp.57-64
• /
• 2010

Purpose: This study aimed to determine whether there are differences in subtalar joint range of motion (ROM) when using different measurement methods, and to determine inter- and intra-rater reliability of goniometry as used in clinical setting. Methods: Subjects were thirty-one healthy males and females (sixty-two ankles) living in Korea. Three raters with different clinical experiences measured inversion and eversion range of motion of the subtalar joint two times. Measurements were done with subjects prone (open kinetic chain) and standing (closed kinetic chain). Rater and measurement methods were based on analyzing differences in range of motion. Intra-class correlation coefficients (ICCs) were calculated to determine intra-rater and inter-rater reliability. Results: Mean subtalar jont range of motion for inversion ranged from $9.31^{\circ}$ to $11.94^{\circ}$ for eversion, it ranged from $6.73^{\circ}$ to $9.20^{\circ}$. The differences in ROM between raters and between measurement methods were significant (p<0.01). The ICCs for interrater reliability ranged from $0.02^{\circ}$ to $0.20^{\circ}$ for inversion and from $0.23^{\circ}$ to $0.39^{\circ}$ for eversion. Intrarater reliability ranged from $0.32^{\circ}$ to $0.78^{\circ}$ for inversion and from $0.45^{\circ}$ to $0.73^{\circ}$ for eversion. Conclusion: Subtalar joint inversion and eversion ROM show differences for measurement methods low reliability between different raters, and low to high intra-rater reliability within sessions.

• 동국한의학연구소논문집
• /
• 제8권2호
• /
• pp.25-46
• /
• 2000

통증은 환자들로 하여금 내원하게 하는 주된 증상중의 하나로, 치료방법의 선택 및 효과 판정을 위해서는 적절한 평가가 필요하다. 통증은 실험적인 방법과 임상적인 방법에 의해 측정될 수 있는데, 통증의 주관적인 성격상 임상적인 방법이 일반적으로 사용된다. 통증의 임상적측정법은 일차원적측정법과 다차원적측정법으로 대별할 수 있는데, 일차원적 측정법으로는 시각적상사척도(Visual Analogue Scale), 구술적평정척도(Verbal Rating Scale), 수치평정척도(Numerical Rating Scale), 통증표정척도(Pain Faces Scale), 그리고 포커칩 도구(Poker Chip Tool)등이 있고, 다차원적 측정법으로는 McGill 동통질문서(McGill Pain Questionnaire), 다면적인성검사(MMPI), 통증행동척도(Pain Behavior Scale), 통증장애지표(Pain Disability Index), 그리고 통증평정척도(Pain Raing Scale)등이 있다. 일차원적 측정법은 주로 환자의 자가통증평가법에 기초하여 통증의 강도를 측정하는데, 측정방법의 단순함과 신속성으로 인해 급성통증을 평가하는데 주로 사용된다. 다차원적인 측정법은 통증의 주관적, 정신적 그리고 행동적인 면을 측정하는데, 측정방법이 포괄적이고 신뢰성이 있어서 만성통증을 측정하는데 사용된다. 환자의 언어와 인지능력은 정확한 통증을 평가하는데 장애가 되는 주된 요인이다. 통증에 따른 행동반응이나 생체반응은 환자의 통증을 완전히 대변하지 못하지만 이러한 상황에 있어 유용한 통증평가지표가 될 수 있다. 통증평가법을 결정할 때에는 먼저 측정하려고 하는 통증의 성격을 고려하여 어떠한 면을 측정할 것인가를 결정해야하며 아울러 환자의 언어와 인지능력을 고려해야 한다. 적절한 평가법의 선택은 환자의 진단과 치료에 있어 유효한 결론에 이르게 하는 중요한 과정이다.

• 대한임상검사과학회지
• /
• 제37권2호
• /
• pp.111-117
• /
• 2005

The purpose of this study is to provide the basic guidelines of spatial and physical environment for the planning and design of clinical laboratory by analysing the extent of satisfaction of clinical laboratory scientists. The data for this analysis was gathered from March to May 2005 by the questionnaires of 208 clinical laboratory scientists who work in the 13 hospitals. All the collected data was analyzed by the SPSSWIN program. In this study, the satisfaction measurement tool was composed with 8 items and 5 score scale. The mean score of satisfaction for spatial and physical environment was 2.89 out of 5.0, "noise" was the lowest 2.40, "temperature and moisture of the lab." was 2.72, "lab. area, service area and administration area" was 2.77, "passageway space" was 2.94, circulation of workers was 2.94, "color of finish" was 3.19, "lighting of lab." was the highest 3.39. In conclusion, various factors, noise, temperature and moisture, clinical lab area, were evaluated to moderate dissatisfaction. Noise was especially the first serious problem in clinical lab. Considering the high growth of the number of tests, the planning of the clinical laboratory size should be considered not only to provide the optimal size but how it will correspond to the growth of the number of tests. Therefore the arrangement of each section need to be flexible in arrangement which is inevitable in expansion and reconstruction in the future.

• 대한임상검사과학회지
• /
• 제39권1호
• /
• pp.31-36
• /
• 2007

The purpose of the clinically reportable range (CRR) in clinical chemistry is to estimate linearity in working range. The reportable range includes all results that may be reliably reported, and embraces two types of ranges: the analytical measurement range (AMR) is the range of analyte values that a method can directly measure on the specimen without any dilution, concentration, or other pretreatment not part of the usual assay process. CAP and JCAHO require linearity on analyzers every six months. The clinically reportable range is the range of analyte values that a method can measure, allowing for specimen dilution, concentration, or other pretreatment used to extend the direct analytical measurement range. The AMR cannot exceed the manufacturer's limits. Establishing AMR is easily accomplished with Calibration Verification Assessment and experimental Linearity. For example: The manufacturer states that the limits of the AST on their instrument are 0-1100. The lowest level that could be verified is 2. The upper level is 1241. The verified AMR of the instrument is 2-1241. The lower limit of the range is 2, because that is the lowest level that could be verified by the laboratory. The laboratory could not use the manufacturer's lower limit of 2 because they have not proven that the instrument values below 2 are valid. The upper limit of the range is 1241, because although the lab has shown that the instrument is linear to 1241, the manufacturer does not make that claim. The laboratory needs to demonstrate the accuracy and precision of the analyzer, as well the validation of the patient AMR. Linearity requirements have been eliminated from the CLIA regulations and from the CAP inspection criteria, however, many inspectors continue to feel that linearity studies are a part of good lab practice and should be encouraged. If a lab chooses to continue linearity studies, these studies must fully comply with the calibration/calibration verification requirements of CLIA and/or CAP. The results of lower limit and upper limit of clinically reportable range were total protein (2.1 - 79.9), albumin (1.3 - 39), total bilirubin (0.2 - 106.2), alkaline phosphatase (13 - 6928.2), aspartate aminotransferase (24 - 7446), alanine aminotransferase (13 - 6724.2), gamma glutamyl transpeptidase (16.64 - 9904.2), creatine kinase (15.26 - 4723.8), lactate dehydrogenase (127.66 - 13231.8), creatinine (0.4 - 129.6), blood urea nitrogen (8.67 - 925.8), uric acid (1.6 - 151.2), total cholesterol (48.52 - 3162), triglycerides (36.91 - 3367.8), glucose (31 - 4218), amylase (21 - 6694.2), calcium (3.1 - 118.2), inorganic phosphorus (1.11 - 108), HDL (11.74 - 666), NA (58.3 - 1800), K (1.0 - 69.6), CL (38 - 1230).

• 대한임상검사과학회지
• /
• 제38권3호
• /
• pp.208-211
• /
• 2006

Microalbuminuria is most frequently caused by kidney damage from diabetes. Moreover, many other conditions can lead to kidney damage, such as high blood pressure, heart failure, cirrhosis, or systemic lupus erythematosus (SLE). The measurement of the microalbumin in urine may be useful for the early diagnosis or as a predictor of nephropathy in diabetes. The most common method for getting a quantitative measurement of urinary protein relies on a 24-hour urine collection. The result of this method is accurate. But 24hr urine collection is difficult to obtain and variations in volume are frequent. Also the patients complain about urine collection. We tried to measure reference values for microalbumin using fasting urine and compare them with the albumin/creatinine ratio using 24hr urine. The concentrations of microalbumin in fasting urine and 24hr urine were $7.1{\pm}3.8mg/L$, $5.7{\pm}2.9mg/L$ (r=0.61, p=0.27), respectively. The albumin/creatinine ratios using fasting urine and 24hr urine were $8.7{\pm}4.2{\mu}g/mg$, $8.7{\pm}4.0{\mu}g/mg$ (r=0.76, p=0.88), respectively. This study indicated that the measurement of microalbumin in fasting urine was an easy and simple method for early diagnosis or to predict nephropathy in diabetes. Thus, setting up the reference value using fasting urine may be useful in the screening test for the diabetic nephropathy patients instead of using the 24hr albumin excretion rate (AER).

• 임상간호연구
• /
• 제16권1호
• /
• pp.177-196
• /
• 2010

Purpose: This study was conducted to develop the nursing process based performance measurement tool and the evidence based care standards for nursing care in medication management and blood transfusion. Methods: The care standards and performance measurement tool were drafted through comprehensive review of relevant literature, national guidelines, hospital protocols, and standards of recognized international accrediting bodies. The proposed care standards and performance measurement tool were reviewed by the panel of experts and refined based on the panel's suggestions. Final care standards and performance measurement tool were validated by surveying the hospital nurses. Results: All items of the performance measurement tool for medication management and blood transfusion were evaluated appropriate. All contents of care standards and the measurable elements except the evaluation of discharge education were appropriate. The performance measurement tool developed in this study was found to be acceptable as a tool to evaluate quality of nursing care in medication management and blood transfusion. Conclusion: The outcomes of this study including the performance measurement tool and evidence based care standards would be the important indicators to monitor whether necessary nursing care is implemented and be the useful primary resources to improve quality of nursing care services.

• Korean Circulation Journal
• /
• 제52권3호
• /
• pp.198-204
• /
• 2022

Blood pressure measurement (BPM) is an essential part of medical examination, and therefore accuracy of BPM devices is crucial. Over the past few years, there has been a rise in new BPM techniques using photoplethysmographic (PPG) signals and complex algorithms for blood pressure estimation. Especially the combination of a mobile device or a smartphone with a camera using PPG may potentially revolutionize BPM in the future. The first-ever BPM application to be approved as a medical device was one by the Korean Ministry of Food and Drug Safety in 2020, despite the lack of robust scientific evidence proving its validity. While the prospect of using these novel BPM devices is an opportunity, there are also some critical issues around calibration and utility in different patient groups that need to be resolved before they can be incorporated into daily clinical practice.

• 한국임상수의학회지
• /
• 제24권4호
• /
• pp.573-576
• /
• 2007

The purpose of this study was to evaluate the relationship between periodontal disease and halitosis, and to develop a detail clinical protocol for assessing halitosis in animals. We measured the periodontal disease parameters, the degree of halitosis using organoleptic scale method and the concentration of volatile sulfur compounds(VSC) using portable sulfide monitor($Halimeter^{TM}$). In this study, VSC levels by $Halimeter^{TM}$ were found to be significantly associated with periodontal disease parameters(plaque index, calculus index)(P<0.05). We also found that conscious sedation did not affect the measurement of VSC levels.